• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评价一种地奥司明衍生物作为抗利什曼原虫药物和潜在的利什曼原虫鸟氨酸脱羧酶调节剂。

Evaluation of a diospyrin derivative as antileishmanial agent and potential modulator of ornithine decarboxylase of Leishmania donovani.

机构信息

Department of Pharmaceutical Technology, Jadavpur University, Kolkata 700 032, India.

出版信息

Exp Parasitol. 2013 Oct;135(2):407-13. doi: 10.1016/j.exppara.2013.07.021. Epub 2013 Aug 20.

DOI:10.1016/j.exppara.2013.07.021
PMID:23973194
Abstract

World health organization has called for academic research and development of new chemotherapeutic strategies to overcome the emerging resistance and side effects exhibited by the drugs currently used against leishmaniasis. Diospyrin, a bis-naphthoquinone isolated from Diospyros montana Roxb., and its semi-synthetic derivatives, were reported for inhibitory activity against protozoan parasites including Leishmania. Presently, we have investigated the antileishmanial effect of a di-epoxide derivative of diospyrin (D17), both in vitro and in vivo. Further, the safety profile of D17 was established by testing its toxicity against normal macrophage cells (IC₅₀∼20.7 μM), and also against normal BALB/c mice in vivo. The compound showed enhanced activity (IC₅₀∼7.2 μM) as compared to diospyrin (IC₅₀∼12.6 μM) against Leishmania donovani promastigotes. Again, D17 was tested on L. donovani BHU1216 isolated from a sodium stibogluconate-unresponsive patient, and exhibited selective inhibition of the intracellular amastigotes (IC₅₀∼0.18 μM). Also, treatment of infected BALB/c mice with D17 at 2mg/kg/day reduced the hepatic parasite load by about 38%. Subsequently, computational docking studies were undertaken on selected enzymes of trypanothione metabolism, viz. trypanothione reductase (TryR) and ornithine decarboxylase (ODC), followed by the enzyme kinetics, where D17 demonstrated non-competitive inhibition of the L. donovani ODC, but could not inhibit TryR.

摘要

世界卫生组织呼吁开展学术研究和开发新的化疗策略,以克服目前用于治疗利什曼病的药物所表现出的耐药性和副作用。从柿树 Diospyros montana Roxb. 中分离得到的双萘醌二苯并吡喃酮及其半合成衍生物被报道对原生动物寄生虫包括利什曼原虫具有抑制活性。目前,我们已经研究了二苯并吡喃酮的二环氧衍生物(D17)的抗利什曼原虫作用,包括在体外和体内。此外,通过测试 D17 对正常巨噬细胞(IC₅₀∼20.7 μM)的毒性以及在体内对正常 BALB/c 小鼠的毒性,确定了 D17 的安全性特征。与二苯并吡喃酮(IC₅₀∼12.6 μM)相比,该化合物对利什曼原虫 Donovan 前鞭毛体的活性增强(IC₅₀∼7.2 μM)。此外,D17 还在从对葡甲胺锑酸钠无反应的患者中分离出的 L. donovani BHU1216 上进行了测试,对细胞内无鞭毛体表现出选择性抑制(IC₅₀∼0.18 μM)。同样,用 D17 以 2mg/kg/天的剂量治疗感染的 BALB/c 小鼠可使肝寄生虫负荷减少约 38%。随后,对几种硫醇代谢相关酶,即硫醇还原酶(TryR)和鸟氨酸脱羧酶(ODC)进行了计算机对接研究,并进行了酶动力学研究,结果表明 D17 对 L. donovani ODC 具有非竞争性抑制作用,但不能抑制 TryR。

相似文献

1
Evaluation of a diospyrin derivative as antileishmanial agent and potential modulator of ornithine decarboxylase of Leishmania donovani.评价一种地奥司明衍生物作为抗利什曼原虫药物和潜在的利什曼原虫鸟氨酸脱羧酶调节剂。
Exp Parasitol. 2013 Oct;135(2):407-13. doi: 10.1016/j.exppara.2013.07.021. Epub 2013 Aug 20.
2
Molecular Modeling and Virtual Screening Approach to Discover Potential Antileishmanial Inhibitors Against Ornithine Decarboxylase.发现针对鸟氨酸脱羧酶的潜在抗利什曼原虫抑制剂的分子建模与虚拟筛选方法
Comb Chem High Throughput Screen. 2016;19(10):813-823. doi: 10.2174/1386207319666160907100134.
3
Apoptosis-like death in Leishmania donovani promastigotes induced by diospyrin and its ethanolamine derivative.地奥配辛及其乙醇胺衍生物诱导利什曼原虫前鞭毛体发生类似细胞凋亡的死亡。
Int J Antimicrob Agents. 2009 Dec;34(6):596-601. doi: 10.1016/j.ijantimicag.2009.08.007. Epub 2009 Sep 26.
4
Leishmania donovani ornithine decarboxylase is indispensable for parasite survival in the mammalian host.杜氏利什曼原虫鸟氨酸脱羧酶对于该寄生虫在哺乳动物宿主体内的存活至关重要。
Infect Immun. 2009 Feb;77(2):756-63. doi: 10.1128/IAI.01236-08. Epub 2008 Dec 8.
5
Diospyrin, a bisnaphthoquinone: a novel inhibitor of type I DNA topoisomerase of Leishmania donovani.柿皮素,一种双萘醌:杜氏利什曼原虫I型DNA拓扑异构酶的新型抑制剂。
Mol Pharmacol. 1998 Dec;54(6):994-9. doi: 10.1124/mol.54.6.994.
6
Leishmania donovani: impairment of the cellular immune response against recombinant ornithine decarboxylase protein as a possible evasion strategy of Leishmania in visceral leishmaniasis.杜氏利什曼原虫:针对重组鸟氨酸脱羧酶蛋白的细胞免疫反应受损,这可能是利什曼原虫在内脏利什曼病中的一种逃避策略。
Int J Parasitol. 2015 Jan;45(1):33-42. doi: 10.1016/j.ijpara.2014.08.013. Epub 2014 Oct 15.
7
One-Pot Synthesis and Evaluation of Antileishmanial Activities of Functionalized S-Alkyl/Aryl Benzothiazole-2-carbothioate Scaffold.功能化 S-烷基/芳基苯并噻唑-2-硫代羧酸酯支架的一锅法合成及其抗利什曼原虫活性评估
J Org Chem. 2016 Apr 15;81(8):3149-60. doi: 10.1021/acs.joc.6b00113. Epub 2016 Apr 6.
8
Antileishmanial effect of 3-aminooxy-1-aminopropane is due to polyamine depletion.3-氨基氧基-1-氨基丙烷的抗利什曼原虫作用归因于多胺耗竭。
Antimicrob Agents Chemother. 2007 Feb;51(2):528-34. doi: 10.1128/AAC.01055-06. Epub 2006 Nov 13.
9
Spinigerin induces apoptotic like cell death in a caspase independent manner in Leishmania donovani.旋光棘蝇诱导利什曼原虫中的胱天蛋白酶非依赖性凋亡样细胞死亡。
Exp Parasitol. 2013 Dec;135(4):715-25. doi: 10.1016/j.exppara.2013.10.011. Epub 2013 Nov 1.
10
In vivo and in vitro antileishmanial activity of Bungarus caeruleus snake venom through alteration of immunomodulatory activity.通过改变免疫调节活性,蓝环蛇蛇毒的体内和体外抗利什曼原虫活性。
Exp Parasitol. 2013 Sep;135(1):126-33. doi: 10.1016/j.exppara.2013.06.006. Epub 2013 Jul 3.

引用本文的文献

1
Putrescine Depletion in Parasites Causes Immediate Proliferation Arrest Followed by an Apoptosis-like Cell Death.寄生虫中腐胺的消耗会导致其立即停止增殖,随后发生类似凋亡的细胞死亡。
Pathogens. 2025 Feb 2;14(2):137. doi: 10.3390/pathogens14020137.
2
Low doses of 3-phenyl-lawsone or meglumine antimoniate delivery by tattooing route are successful in reducing parasite load in cutaneous lesions of () -infected hamsters.纹身途径给予低剂量的 3-苯基-劳森或葡甲胺锑可成功降低 () 感染仓鼠皮肤损伤中的寄生虫负荷。
Front Cell Infect Microbiol. 2023 Jan 19;13:1025359. doi: 10.3389/fcimb.2023.1025359. eCollection 2023.
3
Polyamine Metabolism in Parasites: A Promising Therapeutic Target.
寄生虫中的多胺代谢:有前途的治疗靶点。
Med Sci (Basel). 2022 Apr 22;10(2):24. doi: 10.3390/medsci10020024.
4
The anti-Leishmania potential of bioactive compounds derived from naphthoquinones and their possible applications. A systematic review of animal studies.来源于萘醌类化合物的生物活性化合物的抗利什曼原虫潜力及其可能的应用。动物研究的系统评价。
Parasitol Res. 2022 May;121(5):1247-1280. doi: 10.1007/s00436-022-07455-1. Epub 2022 Feb 22.
5
Potential Anti-leishmanial Activity of a Semi-purified Fraction Isolated from the Leaves of Parthenium hysterophorus.从泽兰叶中分离得到的半纯化部分的潜在抗利什曼原虫活性。
Acta Parasitol. 2021 Dec;66(4):1480-1489. doi: 10.1007/s11686-021-00416-1. Epub 2021 Jun 2.
6
Naphthoquinone Derivatives as Scaffold to Develop New Drugs for Tuberculosis Treatment.以萘醌衍生物为骨架开发治疗结核病的新药
Front Microbiol. 2018 Apr 9;9:673. doi: 10.3389/fmicb.2018.00673. eCollection 2018.
7
Exploring Leishmania secretory proteins to design B and T cell multi-epitope subunit vaccine using immunoinformatics approach.利用免疫信息学方法探索利什曼原虫分泌蛋白,设计 B 和 T 细胞多表位亚单位疫苗。
Sci Rep. 2017 Aug 15;7(1):8285. doi: 10.1038/s41598-017-08842-w.
8
Cinnamic Acid Bornyl Ester Derivatives from Valeriana wallichii Exhibit Antileishmanial In Vivo Activity in Leishmania major-Infected BALB/c Mice.来自缬草的肉桂酸龙脑酯衍生物在感染硕大利什曼原虫的BALB/c小鼠中表现出体内抗利什曼原虫活性。
PLoS One. 2015 Nov 10;10(11):e0142386. doi: 10.1371/journal.pone.0142386. eCollection 2015.
9
Investigational drugs for visceral leishmaniasis.用于内脏利什曼病的研究性药物。
Expert Opin Investig Drugs. 2015 Jan;24(1):43-59. doi: 10.1517/13543784.2014.954035. Epub 2014 Nov 20.